Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer

Table 4

Comparative analysis according to the prognostic factors for NGAL.

	Mean	Median	Min	Max
Endometroid/non-endometroid	176/193	175/191	132/139	190/240	0.054
G1/G2	142/161	144/168	120/126	172/180	0.081
G1/G3	142/191	144/201	121/168	172/240	0.003
FIGO I and II/FIGO III and IV	140/220	142/226	123/178	179/280	0.001
Vascular invasion (±)	152/203	149/201	120/170	179/258	0.002
Lymph vessel invasion (±)	156/213	160/221	136/177	180/262	0.003
Lymph node metastasis (±)	155/231	157/230	131/180	179/281	0.001
Infiltrate the myometrium superficial/deep	158/185	156/186	140/149	182/232	0.066